Tamala, Cherry L.

HRN: 09-41-01  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2024
CEFUROXIME 500MG (TAB)
03/22/2024
03/29/2024
PO
500mg
BID X 7 Days
S/P NSVD With RMLE And Repair
Checking Final Appropriateness 
03/23/2024
METRONIDAZOLE 500MG (TAB)
03/23/2024
03/30/2024
PO
500mg
TID X 7 Days
S/P NSVD With RMLE And Repair
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: